Becker, Crowley, Esserman & Heapy Win Grant Through NIH HEAL Initiative
Yale School of Medicine (YSM) faculty William C. Becker, MD, associate professor (general internal medicine); Susan Crowley, MD, FASN, professor of medicine (nephrology); and Alicia Heapy, PhD; associate professor of psychiatry; teamed with Yale School of Public Health’s (YSPH) Denise Esserman, PhD, associate professor of biostatistics, were recently awarded a grant for their project, “Video-Telecare Collaborative Pain Management to Improve Function and Reduce Opioid Risk in Patients with End Stage Renal Disease Receiving Hemodialysis” through The Helping to End Addiction Long-term, or the NIH HEAL Initiative.
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Physicians Should Play a New Role in Reducing Gun Violence
What if firearm deaths could be reduced by visits to the doctor? More than 35,000 Americans are killed annually by gunfire, about 60% of which are from suicide. The remaining deaths are mostly from accidental injury or homicide. Mass shootings represent only a tiny fraction of that number.
Meet Yale Internal Medicine: Inderjit Singh, MBChB, BMedSci, MRCP, Assistant Professor of Medicine (Pulmonary, Critical Care, and Sleep Medicine) and Director, Pulmonary Vascular Disease Program.
As part of our “Meet Yale Internal Medicine” series, today’s feature is on Inderjit Singh, MBChB, BMedSci, MRCP, assistant professor of medicine (pulmonary, critical care, and sleep medicine) and director, Pulmonary Vascular Disease Program.
Yale investigators awarded grant for opioid addiction treatment
Dr. Emily Wang is the principal investigator for research supported by a grant from the National Institute on Drug Abuse. The purpose of the research is to improve opioid addiction treatment in criminal justice settings. The grant, totaling more than $11 million, supports the five-year project period.
Herold Is Designated C.N.H. Long Professor
Kevan Herold, MD, newly named as C.N.H. Long Professor of Immunobiology and of Medicine, conducts research on the basis for autoimmune diseases and develops new therapies based on these studies. His focus has largely been in the field of autoimmune Type 1 diabetes.
The DNA Damage Response is a Potential Treatable Trait For COPD, Says Sauler
The August 1, 2019 Department of Internal Medicine’s Medical Grand Rounds, “Chronic Obstructive Pulmonary Disease (COPD): Old Myths, New Mechanisms,” was presented by Maor Sauler, MD, assistant professor of medicine (pulmonary, critical care, and sleep medicine).
Yale and Mayo Clinic Awarded FDA Grant to Study Opioid Prescribing and Use
Yale University and Mayo Clinic have been awarded a grant for up to $5.3 million over two years by the U.S. Food and Drug Administration (FDA) to study patients’ experiences with pain and use of opioids prescribed for acute pain. This project is part of the Center of Excellence in Regulatory Science and Innovation (CERSI), a joint effort between Yale, Mayo Clinic, and the FDA. The study will be conducted in collaboration with Regional Health of Rapid City, S.D., and University of Alabama at Birmingham (UAB).
Gene Plays Role in Early-Onset Heart Disease and Diabetes
When heart disease affects people under age 50, it’s considered “early onset” and experts believe there’s a genetic link. Yale investigators have found that a particular gene is common to families with multiple members who either have early-onset heart disease or are at risk for it.
Vilarinho and Wilson Win 2019 Clinical Scientist Development Awards
Yale School of Medicine Department of Internal Medicine’s Silvia Vilarinho, MD, PhD, assistant professor of medicine (digestive diseases) and of pathology, and Frederick Wilson, MD, PhD, assistant professor of medicine (medical oncology) and genetics, are winners of a 2019 Clinical Scientist Development Award (CSDA) from the Doris Duke Charitable Foundation (DDCF).
Serious Falls Are a Health Risk for Adults Under 65
Adults who take several prescription medications are more likely to experience serious falls, say Yale researchers and their co-authors in a new study. This heightened risk can affect middle-aged individuals — a population not typically viewed as vulnerable to debilitating or fatal falls, the researchers said.